SLC5A2 and hydrops fetalis: The favorable effects of SGLT-2 inhibitors among patients with HF could be attributed to the increased production of ketones, which, in turn, ameliorates the mitochondrial dysfunction observed in HF and increases Adenosine triphosphate (ATP) production, thus leading to improved ventricular contractility [38,39,40,41].